Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with MASH and other diseases with ...

Under the liquidity contract granted to Kepler Cheuvreux by Inventiva, the following resources were available in the liquidity account as of 31 December 2024: Cash: € 349,630.55 Number of shares ...

Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with MASH and other diseases with ...

Kepler Cheuvreux initiated coverage of Rotork (RTOXF) with a Buy rating and 390 GBp price target The firm cites the company’s debt-free balance sheet and strong fundamentals for the Buy rating.

On Wednesday, Kepler Cheuvreux began covering Kaufman & Broad S.A. (KOF:FP) (OTC: KFMNF) with a Buy rating and set a price target of €39.10. The firm's analysts pointed to the structural trends ...

On Wednesday, Kepler Cheuvreux initiated coverage on Nexity (EPA:NEXI) SA (NXI:FP), a prominent player in the French real estate market, assigning a Hold rating to the company's shares.

MIKE LORIGAN, REPORTER: To the naked eye, the old prospecting town of Bendigo might not seem the most obvious place to unearth elite marathon running gold but as the saying goes: ARCHIVAL ...

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles Anne Pierre de Kat was a Belgian painter who was born in 1881. How much does an ...

Ms Ruston discussed the issue with Sky News Australia on Tuesday. Picture: Dan Peled / NCA NewsWire “You just have to look at Peter Dutton's record as Health Minister, which, frankly ...

PARIS--(BUSINESS WIRE)--Regulatory News: As regards the liquidity contract awarded by 74Software (Paris:74SW) to Kepler Cheuvreux, on December 31, 2024, the following means were listed in the ...